Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

被引:0
|
作者
van Mulligen, Elise [1 ,2 ]
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands
[2] Erasmus MC, Dept Rheumatol, Rotterdam, Netherlands
来源
LANCET RHEUMATOLOGY | 2024年 / 6卷 / 05期
关键词
D O I
10.1016/S2665-9913(24)00038-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:e254 / e255
页数:2
相关论文
共 50 条
  • [21] Moving towards IMPROVED drug-free remission
    Vivian P. Bykerk
    Nature Reviews Rheumatology, 2018, 14 : 191 - 192
  • [22] Moving towards IMPROVED drug-free remission
    Bykerk, Vivian P.
    NATURE REVIEWS RHEUMATOLOGY, 2018, 14 (04) : 193 - 194
  • [23] Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS
    Jayakumar, Keeranur
    Norton, Sam
    Dixey, Josh
    James, David
    Gough, Andrew
    Williams, Peter
    Prouse, Peter
    Young, Adam
    RHEUMATOLOGY, 2012, 51 (01) : 169 - 175
  • [24] RHEUMATOID ARTHRITIS Can we achieve true drug-free remission in patients with RA?
    Goekoop-Ruiterman, Yvonne P. M.
    Huizinga, Tom W. J.
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (02) : 68 - 70
  • [25] TAPERING OF CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN SUSTAINED RHEUMATOID ARTHRITIS REMISSION: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
    Lillegraven, S.
    Sundlisaeter, N. P.
    Aga, A. B.
    Sexton, J.
    Olsen, I.
    Fremstad, H.
    Spada, C.
    Madland, T. M.
    Hoili, C. A.
    Bakland, G.
    Lexberg, A.
    Hansen, I. J. Widding
    Hansen, I. M.
    Haukeland, H.
    Ljosa, K. A.
    Moholt, E.
    Uhlig, T.
    Solomon, D.
    Van der Heijde, D.
    Kvien, T. K.
    Haavardsholm, E. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1008 - 1009
  • [26] Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review
    Gul, Hanna
    Harnden, Kate
    Saleem, Benazir
    HEALTHCARE, 2021, 9 (12)
  • [27] Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms
    Ajeganova, S.
    van Steenbergen, H. W.
    van Nies, J. A. B.
    Burgers, L. E.
    Huizinga, T. W. J.
    van der Helm-van Mil, A. H. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 867 - 873
  • [28] PREDICTION OF SUSTAINED BIOLOGIC AND TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUG FREE REMISSION IN RHEUMATOID ARTHRITIS PATIENTS
    Burkard, T.
    Williams, R. D.
    Vallejo-Yague, E.
    Hugle, T.
    Finkch, A.
    Kyburz, D.
    Burden, A. M.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S333 - S333
  • [29] OUTCOME AND PREDICTORS OF RELAPSE IN EARLY RHEUMATOID ARTHRITIS PATIENTS ACHIEVING DMARDS-INDUCED STABLE REMISSION DURING DRUG-FREE FOLLOW-UP
    Manzo, A.
    Benaglio, F.
    Sakellariou, G.
    Scarabelli, M.
    Binda, E.
    Vitolo, B.
    Bugatti, S.
    Caporali, R.
    Montecucco, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A93 - A93
  • [30] Tapering of Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients in Sustained Remission: Results from a Randomized Controlled Trial
    Lillegraven, Siri
    Sundlisater, Nina
    Aga, Anna-Birgitte
    Sexton, Joe
    Olsen, Inge Christoffer
    Fremstad, Hallvard
    Spada, Cristina
    Madland, Tor Magne
    Hoili, Christian
    Bakland, Gunnstein
    Lexberg, Ase
    Hansen, Inger Johanne Widding
    Hansen, Inger Myrnes
    Haukeland, Hilde
    Ljosa, Maud-Kristine Aga
    Moholt, Ellen
    Uhlig, Till
    Solomon, Daniel
    van der Heijde, Desiree
    Kvien, Tore
    Haavardsholm, Espen A.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71